Time | Venue: Room 1 | ||
1330 - 1600 | China Session | ||
1615 - 1645 | RCOG Keynote 1: Why do we need a women's health strategy? Prof. Dame Lesley Regan, United Kingdom |
||
1645 - 1715 | RCOG Keynote 2: How to reduce OASIS and its consequences to women? Dr. Ranee Thakar, United Kingdom |
||
1715 - 1745 | Plenary Lecture 1: Over-medicalisation in women's health: is it our future? Prof. Ben Mol, Australia |
||
1800 - 1830 | Opening Ceremony and Welcoming Address | ||
1830 - 1900 | HKCOG Presidential Lecture | ||
1900 - 1930 | Welcome Reception |
Time | Venue: Room 1 | Venue: Room 2 | Venue: Room 3 |
0830 - 0900 | Plenary Lecture 2: Introduction of structured O&G training programme in China Prof. Hextan Ngan, Hong Kong |
||
0900 - 0930 | Plenary Lecture 3: The obstetrician-gynaecologist as leader in women's healthcare Dr. Verda J. Hicks, United States |
||
0940 - 1040 | Session 1: Fetal growth restriction Screening, monitoring and diagnosis of FGR Prevention and treatment for intrauterine growth restriction |
Session 2: Intrapartum care Induction of labour – what’s new? Intrapartum ultrasound at second stage and beyond |
Session 3: Reproductive Surgery Modern management of uterine septum Endometriosis and infertility : when should surgery be done |
1040 - 1110 | Coffee Break | ||
1110 - 1225 | Session 4: Fetal therapy Shunting for fetal pleural effusion In utero therapy for fetal arrhythmia |
Session 5: Preinvasive lesions in the lower genital tract Asian strategy on cervical cancer elimination |
Session 6: Infertility and assisted reproduction Use of adjuncts in IVF Novel technology and preimplantation genetic testing application |
1225 - 1330 | Lunch Break | ||
1330 - 1445 | Session 7: Fetal anomalies Normal and abnormal fetal cerebral cortical development Logics of fetal cardiology |
Session 8: Cancer genetics Hereditary cancer syndromes beyond Lynch syndrome and HBOC Endometrial cancer diagnosis beyond WHO classification 2020 |
Session 9: Reproductive endocrinology Menopausal hormone therapy: friend or foe? Management of recurrent miscarriage: how much should we do? |
1445 - 1515 | Coffee Break | ||
1515 - 1630 | Session 10: Hypertensive disorder in pregnancy Use of biomarkers for short term prediction of preeclampsia Safe ride in high tide - hypertensive emergency in pregnancy |
Session 11: Pelvic organ prolapse Management of advanced stage of pelvic organ prolapse Vaginal mesh use and national registry |
Session 12: Sexual and reproductive health Safe abortion: new updates Recent developments in contraception |
1640 - 1710 | Plenary Lecture 4: Global disruptions as an opportunity in global women's health Dr. Anne Beatrice Kihara, Kenya |
||
1710 - 1740 | Plenary Lecture 5: Advances in fetal therapy in Hong Kong Prof. Tak-Yeung Leung, Hong Kong |
||
1830 - 1930 | Conferment Ceremony | ||
1945 - 2200 | Gala Dinner |
Time | Venue: Room 1 | Venue: Room 2 | Venue: Room 3 |
0830 - 0900 | Plenary Lecture 6: Implementation of pre-eclampsia screening and prevention in Asia Prof. Liona Poon, Hong Kong |
||
0900 - 0930 | Plenary Lecture 7: Improving the clinical utility of prenatal next generation sequencing investigation of the fetus with congenital malformations Prof. Mark Kilby, United Kingdom |
||
0940 - 1040 | Session 13: Critical care in obstetrics Massive transfusion protocol/application of thromboelastography in the management of PPH and DIC in obstetrics Management of placenta acreta spectrum disorder – Experience in China
|
Session 14: Perinatal genetics Implementation of Public Funded Genome Sequencing in Evaluation of Fetal Structural Anomalies Concurrent non-invasive prenatal screening for genetic disorders of heterogenous etiologies: a prospective, multicenter cohort study |
Session 15: Menstrual problems Evidence-based management of abnormal uterine bleeding in fibroids Updates in management of adenomyosis |
1040 - 1100 | Coffee Break | ||
1100 - 1215 | Session 16: Preterm birth Microbiome and preterm birth Updates on Cervical Cerclage |
Session 17: Innovation Telemedicine in reproductive health Telehealth – a new door for safe O&G care? Artificial Intelligence in O&G Ultrasound: An Update and Future Applications |
Session 18: Gynaecological endoscopy vNOTES hysterectomy Contained morcellation |
1215 - 1315 | Lunch Break | ||
1315 - 1430 | Session 19: Multiple pregnancy Controversies in the management of twin pregnancy Delay interval delivery in pre- and prei-viable multiple pregnancy |
Session 20: Pregnancy and the pelvic floor Childbirth and pelvic floor trauma Obstetric anal sphincter injury |
Session 21: Acute gynaecology Management of extrauterine pregnancy: lessons to learn Caesarean scar pregnancy |
1430 - 1445 | Coffee Break | ||
1445 - 1600 | Session 22: Postpartum haemorrhage Latest development for placenta accreta spectrum What devices do we have for the management of PPH? Are they fit for purpose? |
Session 23: Gynaecological malignancies Management of metastatic / recurrent endometrial cancer Management of ovarian sex-cord stromal tumours |
Session 24: Paediatric and adolescent gynaecology Eliminating abuse, providing opportunities and restoring better health of adolescents Teenage pregnancy in Hong Kong and across the globe |
1600 - 1615 | Closing Ceremony |
*Program is subject to change without prior notice
HKCOG 35th Anniversary International Conference Secretariat
c/o International Conference Consultants Ltd.
Office Address: Unit C-D, 17/F, Max Share Centre, 373 King's Road, North Point, Hong Kong
Tel: (852) 2559 9973
Fax: (852) 2547 9528
Email: info@hkcog35.org